Kezar Life Sciences Inc. (KZR)
NASDAQ: KZR
· Real-Time Price · USD
4.00
0.02 (0.50%)
At close: Aug 15, 2025, 10:09 AM
0.50% (1D)
| Bid | 3.94 |
| Market Cap | 29.22M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -78.63M |
| EPS (ttm) | -9.7 |
| PE Ratio (ttm) | -0.41 |
| Forward PE | -0.63 |
| Analyst | Hold |
| Ask | 4.07 |
| Volume | 5,963 |
| Avg. Volume (20D) | 46,701 |
| Open | 3.95 |
| Previous Close | 3.98 |
| Day's Range | 3.95 - 4.05 |
| 52-Week Range | 3.62 - 9.20 |
| Beta | 0.65 |
Analyst Forecast
According to 0 analyst ratings, the average rating for KZR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
+42.1%
Kezar Life Sciences shares are trading higher afte...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Kezar Life Sciences to Participate in the Jefferies Global Healthcare ConferenceSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immun...
